[As such, IGF-2 is a molecular marker and potential therapeutic target for the most aggressive epithelial ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE